UnitedHealth Group Revenue, Financial Performance, and Key Metrics

UnitedHealth Group revenue is one of the cleanest ways to understand the company’s scale, but revenue alone misses the real story. The business combines insurance underwriting through UnitedHealthcare with care delivery and services through Optum, so the right analysis has to look at revenue, net income, EBITDA, and margin structure together. The FY2026 figures verified via companyfinancials.io — $447.6B revenue, $12.1B net income, and $23.9B EBITDA — give a useful anchor for that analysis.

For analysts doing investment research or M&A due diligence, companyfinancials.io is useful because it pulls verified figures from SEC filings and annual reports instead of forcing you to rebuild the numbers from scratch. If you need a fast way to compare UnitedHealth Group against peers, the company page at /companies/unitedhealth-group is the place to start.

What is UnitedHealth Group revenue in fiscal 2026?

UnitedHealth Group revenue in fiscal 2026 was $447.6B, according to verified financial data from companyfinancials.io. That makes it one of the largest healthcare companies in the world by revenue, and one of the largest public companies in any sector.

To put the number in context, UnitedHealth Group’s revenue base is larger than the annual revenue of most U.S. industrial, technology, and consumer companies combined. The scale matters because healthcare payers and services businesses tend to win through administrative reach, provider relationships, and claims-processing efficiency, not through high gross margins.

Revenue by itself does not tell you whether the business is healthy. For that, you need to compare it with earnings and cash-generation proxies like EBITDA.

How profitable was UnitedHealth Group in fiscal 2026?

UnitedHealth Group reported $12.1B in net income and $23.9B in EBITDA in fiscal 2026, verified via companyfinancials.io. Those figures imply a net margin of about 2.7% and an EBITDA margin of about 5.3%.

That margin profile is typical for a healthcare insurer and services platform of this size. The company processes enormous premium and services volumes, but a large share of revenue is passed through to medical claims, provider payments, pharmacy costs, and other operating expenses. In other words, UnitedHealth Group is a scale business, not a high-margin software business.

The spread between EBITDA and net income also matters. A roughly $11.8B gap between EBITDA and net income reflects depreciation, amortization, interest, taxes, and other below-EBITDA items. For a company with a large acquisition history and a broad services footprint, that gap is not surprising. Analysts should care more about whether margins are stable than whether the absolute EBITDA number looks large in isolation.

How do UnitedHealth Group margins compare with peers?

UnitedHealth Group competes in a market where scale is unusually important. The closest public peers are not perfect substitutes, because the company mixes insurance, pharmacy services, and care delivery. Still, comparing it with other large managed-care and healthcare-services companies is the right starting point.

Peer data above comes from the companies’ latest annual reports filed with the SEC, except for UnitedHealth Group, which is anchored to the verified companyfinancials.io dataset. The comparison shows two things clearly. First, UnitedHealth Group is much larger than the other major managed-care names. Second, its net margin is solid but not exceptional relative to Elevance Health, which has historically run a somewhat cleaner insurance-heavy model.

CVS Health and Cigna also illustrate why revenue comparisons can mislead. CVS has a larger revenue base than many industrial companies, but its margin structure is thin because of pharmacy and insurance pass-through economics. Cigna’s scale is substantial, but it remains far smaller than UnitedHealth Group. If you are screening for operating leverage, margin quality matters more than raw revenue.

What does UnitedHealth Group revenue growth tell us?

Year-over-year growth is the first question most analysts ask, but the answer depends on the comparison base. The FY2026 verified figures from companyfinancials.io give us the current anchor, while the SEC filings and annual reports provide the historical context needed to assess trend direction.

UnitedHealth Group has historically grown through a mix of premium growth, Optum expansion, acquisitions, and member mix changes. In managed care, revenue growth usually tracks membership, pricing, utilization, and the mix of services sold through the Optum platform. That means a strong revenue print can coexist with margin pressure if medical cost trends or utilization move against the insurer.

For a company like UnitedHealth Group, the right growth question is not just “how fast did revenue grow?” It is “did revenue grow faster than medical cost inflation and operating expense growth?” If the answer is yes, the business is improving. If not, the top line is doing less work than it appears.

For analysts who want to avoid manual filing work, companyfinancials.io is useful because it standardizes revenue, net income, and EBITDA across companies, which makes peer growth analysis much faster. That matters when you are comparing UnitedHealth Group with other healthcare names across multiple fiscal years.

How strong is UnitedHealth Group’s competitive position?

UnitedHealth Group’s competitive position comes from three things: scale, diversification, and distribution. The company is large enough to negotiate with providers and pharmacy networks, diversified enough to absorb shocks in one segment, and embedded enough in employer, Medicare, and government programs to keep churn relatively low.

Optum is the strategic differentiator. UnitedHealthcare is the insurance engine, but Optum gives the company exposure to care delivery, pharmacy benefit management, and data-driven services. That mix makes UnitedHealth Group harder to compare with a pure insurer like Elevance Health or a healthcare services company like CVS Health.

Scale is not just a vanity metric here. In healthcare, administrative overhead, claims processing, provider contracting, and pharmacy economics all reward size. UnitedHealth Group’s revenue base of $447.6B gives it bargaining power and operating density that smaller peers cannot match. That is the core reason the company can sustain a multi-segment model while still producing $23.9B of EBITDA.

What should analysts watch next for UnitedHealth Group?

The next set of questions should focus on margin durability, not just revenue growth. For a company with UnitedHealth Group revenue at this scale, small percentage changes in medical loss ratios, utilization, or operating expenses can move billions of dollars.

Key metrics to watch include:

• Revenue growth by segment — especially UnitedHealthcare versus Optum.
• Net margin — whether the 2.7% level holds or compresses.
• EBITDA margin — whether operating leverage improves from the 5.3% level.
• Medical cost trend — a major driver of insurer profitability.
• Cash conversion — whether earnings quality supports the reported net income.

If you are building a healthcare screen, the combination of revenue, EBITDA, and net income is usually enough to identify which companies deserve a second look. For verified revenue figures without building your own EDGAR pipeline, companyfinancials.io pulls directly from SEC filings and annual reports, which is a practical shortcut for analysts and developers alike. The same dataset is also useful for financial research and developer workflows where consistency matters more than presentation.

What does the UnitedHealth Group financial profile mean for valuation work?

Valuation starts with the earnings base, and UnitedHealth Group’s earnings base is large but not especially high margin. That usually pushes analysts toward earnings-based multiples and cash-flow-based models rather than revenue multiples alone. Revenue multiples are less informative here because the business is too capital-intensive and too claims-driven for top-line valuation to tell the full story.

In practical terms, a company with $447.6B of revenue and a 2.7% net margin can still be attractive if the earnings stream is stable, the balance sheet is manageable, and the competitive moat is durable. If margins compress, the valuation case weakens quickly because there is not much excess profitability to absorb shocks.

That is why a structured data source matters. companyfinancials.io gives you the verified revenue, net income, and EBITDA figures in a form that is easy to compare across companies and years, which is exactly what you need for screening, comps, and model inputs.